(Health-NewsWire.Net, September 14, 2016 ) Other events that are expected to invoke change to the previously stagnant atopic dermatitis market include the launch of a non-steroidal topical from Anacor, AN2728, generic erosion of branded topicals Protopic and Elidel in the US.
GlobalData values the atopic dermatitis market in Japan at $397.0m in 2014. Growth within that market will stem from the positive uptake of systemic agents and the pipeline therapy dupilumab. In terms of branded products, Protopic dominates the topical calcineurin inhibitor class in Japan with estimated sales of $31.5m in 2014. Since its key competitor Elidel is not available in Japan, Protopics strong stance in that market remains relatively unchallenged throughout the 10-year forecast.
*This is an on-demand report and will be delivered within 24 hrs. (excluding weekends) of the purchase.
- Overview of Atopic Dermatitis including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape. - Detailed information on the key drugs in Japan including product Atopic Dermatitiscription, safety and efficacy profiles as well as a SWOT analysis. - Sales forecast for the top drugs in Japan from 2014-2024. - Analysis of the impact of key events as well the drivers and restraints affecting Japan Atopic Dermatitis market.
- Understand and capitalize by identifying products that are most likely to ensure a robust return - Stay ahead of the competition by understanding the changing competitive landscape for Atopic Dermatitis. - Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential - Make more informed business decisions from insightful and in-depth analysis of drug performance - Obtain sales forecast for drugs from 2014-2024 in Japan.
Connect for more details: Sam Collins Market Reports Center Call us : 1-646-883-3044 (US) +91-7709318205 (IND) Email : info@marketreportscenter.com visit our website : https://marketreportscenter.com